101 related articles for article (PubMed ID: 417345)
1. Antipyrine plasma half-life. In vivo indicator of oxidative metabolic capability in Rhesus monkeys (Macaca mulatta).
Miller JL; Clark CR; Gee SJ; Krieger RI
Pharmacology; 1978; 16(5):279-86. PubMed ID: 417345
[TBL] [Abstract][Full Text] [Related]
2. SKF 525-A inhibition of hepatic monooxygenase activity in rhesus monkeys.
Clark CR; Gee SJ; Krieger RI
Pharmacology; 1978; 17(4):201-9. PubMed ID: 99753
[TBL] [Abstract][Full Text] [Related]
3. High speed liquid chromatography, 14C-radioassay and spectrophotometry for measuring antipyrine plasma half-life in rhesus monkeys (Macaca mulatta).
Clark CR; Krieger RI; Miller JL
Pharmacology; 1978; 17(2):98-103. PubMed ID: 98774
[TBL] [Abstract][Full Text] [Related]
4. Monooxygenase-catalyzed aldrin epoxidation and dihydroisodrin hydroxylation in monkey liver needle-biopsy specimens. Assay and properties.
Krieger RI; Gee SJ; Miller JL; Thongsinthusak
Drug Metab Dispos; 1976; 4(1):28-34. PubMed ID: 3398
[TBL] [Abstract][Full Text] [Related]
5. Phenobarbital treatments lower DDT body burden in rhesus monkeys.
Ferguson PW; Clark CR; Gee SJ; Krieger RI
Arch Environ Contam Toxicol; 1981; 10(3):263-70. PubMed ID: 7259297
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic profile of antipyrine in young rhesus monkeys (Macaca mulatta) with protein energy malnutrition.
Sharma B; Mehta S; Nain CK; Mathur VS
Drug Nutr Interact; 1985; 3(2):93-8. PubMed ID: 3921335
[TBL] [Abstract][Full Text] [Related]
7. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
8. On the antipyrine test in laboratory animals. Studies in the dog and monkey.
Vickers FF; Bowman TA; Dvorchik BH; Passananti GT; Hughes DM; Vesell ES
Drug Metab Dispos; 1989; 17(2):160-5. PubMed ID: 2565205
[TBL] [Abstract][Full Text] [Related]
9. Hepatic and metabolic effects of ethanol on rhesus monkeys.
Ruebner BH; Krieger RI; Miller JL; Tsao M; Rorvik M
Adv Exp Med Biol; 1975; 59():395-405. PubMed ID: 810005
[TBL] [Abstract][Full Text] [Related]
10. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
Teunissen MW; Van Graft M; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
[TBL] [Abstract][Full Text] [Related]
11. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo.
Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT
Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054
[TBL] [Abstract][Full Text] [Related]
12. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
Vesell ES; Page JG
J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
[TBL] [Abstract][Full Text] [Related]
13. The plasma half-life of antipyrine in chromic uraemic and normal subjects.
Maddocks JL; Wake CJ; Harber MJ
Br J Clin Pharmacol; 1975 Aug; 2(4):339-43. PubMed ID: 1233993
[TBL] [Abstract][Full Text] [Related]
14. Closed needle liver biopsy for assessment of monooxygenase activity in rhesus monkeys (Macaca mulatta).
Miller JL; Gee SJ; Krieger RI; Ruebner BH
J Med Primatol; 1978; 7(1):1-7. PubMed ID: 96263
[TBL] [Abstract][Full Text] [Related]
15. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
Szakács T; Veres Z; Vereczkey L
Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic drug interactions.
Nies AS; Shand DG; Branch RA
Cardiovasc Clin; 1974; 6(2):43-53. PubMed ID: 4613462
[No Abstract] [Full Text] [Related]
17. 14C-antipyrine as a model compound in the study of drug oxidation and enzyme induction in individual surviving rats.
Bakke OM; Bending M; Aarbakke J; Davies DS
Acta Pharmacol Toxicol (Copenh); 1974 Aug; 35(2):91-7. PubMed ID: 4479350
[No Abstract] [Full Text] [Related]
18. Induction of a deficiency of steroid delta 4-5 alpha-reductase activity in liver by a porphyrinogenic drug.
Kappas A; Bradlow HL; Bickers DR; Alvares AP
J Clin Invest; 1977 Jan; 59(1):159-64. PubMed ID: 830660
[TBL] [Abstract][Full Text] [Related]
19. Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.
Miguet JP; Mavier P; Soussy CJ; Dhumeaux D
Gastroenterology; 1977 May; 72(5 Pt 1):924-6. PubMed ID: 849823
[TBL] [Abstract][Full Text] [Related]
20. Comparative investigation of antipyrine half-life and induction of cytochrome P-450 dependent monooxygenases in rats treated with phenylurea herbicides.
Schoket B; Zilahy Z; Molnar J; Vincze I
In Vivo; 1987; 1(3):185-7. PubMed ID: 2979785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
